中文 | English
Return
Total: 152 , 1/16
Show Home Prev Next End page: GO
Author:(Shu-lin SHEN)

3.Effects of electro-acupuncture at Shuigou (DU26) point on motor evoked potential in rats with cerebral infarction.

Wenping YAO ; Shu WANG ; Lin HAN ; Jinquan MA ; Yan SHEN

Journal of Integrative Medicine 2010;8(10):979-84

4.Transurethral plasmakinetic vaporization of prostate for benign prostatic hyperplasia:a clinical analysis in 180 eases

Hong-Feng SHEN ; Shu-Yong YU ; Lin XIONG ;

Chinese Journal of Primary Medicine and Pharmacy 2006;0(07):-

5.A Rapid Screening Model for Biosurfactant Producing Strains

Chang-Fa NING ; Wei SHEN ; Guang-Rong MENG ; Shu-Lin YANG ;

Microbiology 1992;0(03):-

6.Overview of management system for conflict of interest of the European Pharmacopoeia Commission and the United States Pharmacopoeia Convention

XU Xinyi ; LIU Jian ; ZHANG Lin ; SHEN Xueyao ; ZHAO Jianfeng ; ZHANG Jun ; FU Jian ; SHU Rong

Drug Standards of China 2024;25(1):0103-0108

7.Effect of Paraformaldehyde Fixation on the FRET Efficiency Calculation between Fluorescent Proteins

Hong-Wei SHAO ; Wen-Feng ZHANG ; Qing-Lian HU ; Han SHEN ; Feng-Lin WU ; Shu-Lin HUANG ;

China Biotechnology 2006;0(07):-

8.Evolutionary analysis of neuraminidase gene of A/H7N9 influenza virus.

Yi-Tong SUN ; Neng-Zhi JIN ; Hai-Rong ZHANG ; Yu-Lin SHEN ; Yao MA ; Tian-Shu PENG

Chinese Journal of Virology 2014;30(1):44-50

9.Cloning and expression analysis of pathogenesis-related protein 1 gene of Panax notoginseng.

Rui-Bo LI ; Xiu-Ming CUI ; Yu-Zhong LIU ; Zhi-Gang WU ; Shu-Fang LIN ; Ye SHEN ; Lu-Qi HUANG

Acta Pharmaceutica Sinica 2014;49(1):124-130

10.Correlation between level of TSH receptor antibody and activity of Graves ophthalmopathy after treatment with glucocorticoid

Hai-Bing JU ; Guang-Lin WANG ; Deng-Ming HU ; Zi-Zhen SHU ; Zi-Yin ZHU ; Fei-Fei SHEN ;

Chinese Journal of Endocrinology and Metabolism 2001;0(05):-

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 152 , 1/16 Show Home Prev Next End page: GO